We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
General Motors' (GM) Q3 Earnings Beat Estimate, Improve Y/Y
Read MoreHide Full Article
General Motors Company (GM - Free Report) reported third-quarter 2018 adjusted earnings per share of $1.87, up 41.7% from that of prior-year quarter. Also the bottom line beat the Zacks Consensus Estimate of $1.26. The quarter witnessed robust performance in North America across all-new full-size trucks, and crossovers.
Revenues
General Motors reported revenues of $35.8 billion, up 6.4% from the year ago quarter figure. Also, revenues came in higher than the Zacks Consensus Estimate of $34.2 billion.
Investors should note that the Zacks Consensus Estimate for third-quarter earnings for General Motors has remained unchanged over the past seven days.
General Motors has delivered negative earnings surprise in the last quarter. It surpassed the Zacks Consensus Estimate in three of the trailing four quarters, while missing on one occasion, with an average beat of around 15.5%.
We have highlighted some of the key stats from this just-revealed announcement below:
Key Stats/Developments to Note
During the quarter, General Motors delivered 700,000 vehicles in the United States. Chevrolet Tahoe, Suburban and GMC Yukon full-size SUVs sales rose around 12% year over year.
Zacks Rank
Currently, General Motors has a Zacks Rank #3 (Hold), but that could change following its earnings report which has just released.
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
Image: Bigstock
General Motors' (GM) Q3 Earnings Beat Estimate, Improve Y/Y
General Motors Company (GM - Free Report) reported third-quarter 2018 adjusted earnings per share of $1.87, up 41.7% from that of prior-year quarter. Also the bottom line beat the Zacks Consensus Estimate of $1.26. The quarter witnessed robust performance in North America across all-new full-size trucks, and crossovers.
Revenues
General Motors reported revenues of $35.8 billion, up 6.4% from the year ago quarter figure. Also, revenues came in higher than the Zacks Consensus Estimate of $34.2 billion.
General Motors Company Price and EPS Surprise
General Motors Company Price and EPS Surprise | General Motors Company Quote
Estimate Trend & Surprise History
Investors should note that the Zacks Consensus Estimate for third-quarter earnings for General Motors has remained unchanged over the past seven days.
General Motors has delivered negative earnings surprise in the last quarter. It surpassed the Zacks Consensus Estimate in three of the trailing four quarters, while missing on one occasion, with an average beat of around 15.5%.
We have highlighted some of the key stats from this just-revealed announcement below:
Key Stats/Developments to Note
During the quarter, General Motors delivered 700,000 vehicles in the United States. Chevrolet Tahoe, Suburban and GMC Yukon full-size SUVs sales rose around 12% year over year.
Zacks Rank
Currently, General Motors has a Zacks Rank #3 (Hold), but that could change following its earnings report which has just released.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
See them today for free >>